• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过两种pH敏感脂质膜穿透肽(pHLIP)将二聚体STINGa靶向细胞内递送用于实体瘤治疗。

Targeted intracellular delivery of dimeric STINGa by two pHLIP peptides for treatment of solid tumors.

作者信息

Moshnikova Anna, DuPont Michael, Iraca Marissa, Klumpp Craig, Visca Hannah, Allababidi Dana, Pelzer Phoebe, Engelman Donald M, Andreev Oleg A, Reshetnyak Yana K

机构信息

Physics Department, University of Rhode Island, Kingston, RI, United States.

Department of Chemical Engineering, University of Rhode Island, Kingston, RI, United States.

出版信息

Front Pharmacol. 2024 Mar 1;15:1346756. doi: 10.3389/fphar.2024.1346756. eCollection 2024.

DOI:10.3389/fphar.2024.1346756
PMID:38495104
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10940318/
Abstract

We have developed a delivery approach that uses two pHLIP peptides that collaborate in the targeted intracellular delivery of a single payload, dimeric STINGa (dMSA). dMSA was conjugated with two pHLIP peptides via S-S cleavable self-immolating linkers to form 2pHLIP-dMSA. Biophysical studies were carried out to confirm pH-triggered interactions of the 2pHLIP-dMSA with membrane lipid bilayers. The kinetics of linker self-immolation and dMSA release, the pharmacokinetics, the binding to plasma proteins, the stability of the agent in plasma, the targeting and resulting cytokine activation in tumors, and the biodistribution of the construct was investigated. This is the first study demonstrating that combining the energy of the membrane-associated folding of two pHLIPs can be utilized to enhance the targeted intracellular delivery of large therapeutic cargo payloads. Linking two pHLIPs to the cargo extends blood half-life, and targeted delivery of dimeric STINGa induces tumor eradication and the development of robust anti-cancer immunity.

摘要

我们开发了一种递送方法,该方法使用两种pHLIP肽,它们协同作用于单一负载二聚体STINGa(dMSA)的靶向细胞内递送。通过S-S可裂解的自毁连接子将dMSA与两种pHLIP肽偶联,形成2pHLIP-dMSA。进行了生物物理研究以确认2pHLIP-dMSA与膜脂双层的pH触发相互作用。研究了连接子自毁和dMSA释放的动力学、药代动力学、与血浆蛋白的结合、该制剂在血浆中的稳定性、在肿瘤中的靶向作用以及由此产生的细胞因子激活,以及该构建体的生物分布。这是第一项证明可以利用两种pHLIP的膜相关折叠能量来增强大型治疗性负载的靶向细胞内递送的研究。将两种pHLIP连接到负载上可延长血液半衰期,二聚体STINGa的靶向递送可诱导肿瘤根除并产生强大的抗癌免疫力。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0437/10940318/5d558264525a/fphar-15-1346756-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0437/10940318/a7321c923103/fphar-15-1346756-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0437/10940318/ac84ac8738f8/fphar-15-1346756-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0437/10940318/273226933b1a/fphar-15-1346756-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0437/10940318/5e3c07d7c097/fphar-15-1346756-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0437/10940318/5d558264525a/fphar-15-1346756-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0437/10940318/a7321c923103/fphar-15-1346756-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0437/10940318/ac84ac8738f8/fphar-15-1346756-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0437/10940318/273226933b1a/fphar-15-1346756-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0437/10940318/5e3c07d7c097/fphar-15-1346756-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0437/10940318/5d558264525a/fphar-15-1346756-g005.jpg

相似文献

1
Targeted intracellular delivery of dimeric STINGa by two pHLIP peptides for treatment of solid tumors.通过两种pH敏感脂质膜穿透肽(pHLIP)将二聚体STINGa靶向细胞内递送用于实体瘤治疗。
Front Pharmacol. 2024 Mar 1;15:1346756. doi: 10.3389/fphar.2024.1346756. eCollection 2024.
2
Eradication of tumors and development of anti-cancer immunity using STINGa targeted by pHLIP.使用pHLIP靶向的STING消除肿瘤并发展抗癌免疫。
Front Oncol. 2022 Oct 18;12:1023959. doi: 10.3389/fonc.2022.1023959. eCollection 2022.
3
Peptides of pHLIP family for targeted intracellular and extracellular delivery of cargo molecules to tumors.pHLIP 家族肽用于将货物分子靶向递送至肿瘤的细胞内和细胞外。
Proc Natl Acad Sci U S A. 2018 Mar 20;115(12):E2811-E2818. doi: 10.1073/pnas.1715350115. Epub 2018 Mar 5.
4
Aiming the magic bullet: targeted delivery of imaging and therapeutic agents to solid tumors by pHLIP peptides.瞄准神奇子弹:通过pHLIP肽将成像和治疗剂靶向递送至实体瘤
Front Pharmacol. 2024 Mar 13;15:1355893. doi: 10.3389/fphar.2024.1355893. eCollection 2024.
5
pH-sensitive membrane peptides (pHLIPs) as a novel class of delivery agents.pH敏感膜肽(pHLIPs)作为一类新型的递送剂。
Mol Membr Biol. 2010 Oct;27(7):341-52. doi: 10.3109/09687688.2010.509285. Epub 2010 Oct 13.
6
Pharmacokinetic modeling reveals parameters that govern tumor targeting and delivery by a pH-Low Insertion Peptide (pHLIP).药代动力学模型揭示了 pH-低插入肽(pHLIP)靶向和递送至肿瘤的参数。
Proc Natl Acad Sci U S A. 2021 Jan 5;118(1). doi: 10.1073/pnas.2016605118. Epub 2020 Dec 21.
7
Targeting Bladder Urothelial Carcinoma with pHLIP-ICG and Inhibition of Urothelial Cancer Cell Proliferation by pHLIP-amanitin.用pH敏感脂质体-吲哚菁绿靶向膀胱尿路上皮癌及用pH敏感脂质体-鹅膏蕈碱抑制尿路上皮癌细胞增殖
Front Urol. 2022;2. doi: 10.3389/fruro.2022.868919. Epub 2022 Aug 24.
8
Membrane-Induced p K Shifts in wt-pHLIP and Its L16H Variant.膜诱导 wt-pHLIP 及其 L16H 变体的 pK 位移。
J Chem Theory Comput. 2018 Jun 12;14(6):3289-3297. doi: 10.1021/acs.jctc.8b00102. Epub 2018 May 17.
9
Tumor treatment by pHLIP-targeted antigen delivery.通过pHLIP靶向抗原递送进行肿瘤治疗。
Front Bioeng Biotechnol. 2023 Jan 6;10:1082290. doi: 10.3389/fbioe.2022.1082290. eCollection 2022.
10
Cy5.5-labeled pH low insertion peptide (pHLIP)Cy5.5标记的低pH插入肽(pHLIP)

引用本文的文献

1
Intracellular delivery strategies using membrane-interacting peptides and proteins.利用膜相互作用肽和蛋白质的细胞内递药策略。
Nanoscale. 2024 Aug 22;16(33):15465-15480. doi: 10.1039/d4nr02093f.

本文引用的文献

1
Epigenetic state determines the in vivo efficacy of STING agonist therapy.表观遗传状态决定了 STING 激动剂治疗的体内疗效。
Nat Commun. 2023 Mar 22;14(1):1573. doi: 10.1038/s41467-023-37217-1.
2
Tumor-targeted delivery of a STING agonist improvescancer immunotherapy.肿瘤靶向递送 STING 激动剂可改善癌症免疫治疗。
Proc Natl Acad Sci U S A. 2022 Dec 6;119(49):e2214278119. doi: 10.1073/pnas.2214278119. Epub 2022 Nov 29.
3
Targeting Bladder Urothelial Carcinoma with pHLIP-ICG and Inhibition of Urothelial Cancer Cell Proliferation by pHLIP-amanitin.
用pH敏感脂质体-吲哚菁绿靶向膀胱尿路上皮癌及用pH敏感脂质体-鹅膏蕈碱抑制尿路上皮癌细胞增殖
Front Urol. 2022;2. doi: 10.3389/fruro.2022.868919. Epub 2022 Aug 24.
4
Eradication of tumors and development of anti-cancer immunity using STINGa targeted by pHLIP.使用pHLIP靶向的STING消除肿瘤并发展抗癌免疫。
Front Oncol. 2022 Oct 18;12:1023959. doi: 10.3389/fonc.2022.1023959. eCollection 2022.
5
STING agonist delivery by tumour-penetrating PEG-lipid nanodiscs primes robust anticancer immunity.肿瘤穿透性 PEG-脂质纳米盘递送 STING 激动剂可引发强大的抗癌免疫。
Nat Mater. 2022 Jun;21(6):710-720. doi: 10.1038/s41563-022-01251-z. Epub 2022 May 23.
6
Activation of STING in the pancreatic tumor microenvironment: A novel therapeutic opportunity.胰腺肿瘤微环境中STING的激活:一种新的治疗契机。
Cancer Lett. 2022 Jul 10;538:215694. doi: 10.1016/j.canlet.2022.215694. Epub 2022 Apr 27.
7
Epigenetic STING silencing is developmentally conserved in gliomas and can be rescued by methyltransferase inhibition.表观遗传沉默信号调节蛋白(STING)在胶质瘤中具有发育保守性,并且可以通过甲基转移酶抑制作用得到挽救。
Cancer Cell. 2022 May 9;40(5):439-440. doi: 10.1016/j.ccell.2022.04.009. Epub 2022 Apr 28.
8
Tumor-selective, antigen-independent delivery of a pH sensitive peptide-topoisomerase inhibitor conjugate suppresses tumor growth without systemic toxicity.肿瘤选择性、抗原非依赖性递送一种pH敏感肽-拓扑异构酶抑制剂偶联物可抑制肿瘤生长且无全身毒性。
NAR Cancer. 2021 Jun 4;3(2):zcab021. doi: 10.1093/narcan/zcab021. eCollection 2021 Jun.
9
The cGAS-STING pathway as a therapeutic target in inflammatory diseases.cGAS-STING 通路作为炎症性疾病的治疗靶点。
Nat Rev Immunol. 2021 Sep;21(9):548-569. doi: 10.1038/s41577-021-00524-z. Epub 2021 Apr 8.
10
Epigenetic reprogramming of tumor cell-intrinsic STING function sculpts antigenicity and T cell recognition of melanoma.肿瘤细胞内在 STING 功能的表观遗传重编程塑造了黑色素瘤的抗原性和 T 细胞识别。
Proc Natl Acad Sci U S A. 2021 Apr 13;118(15). doi: 10.1073/pnas.2013598118.